BASKING RIDGE, N.J. and PITTSBURGH, July 31, 2012 /PRNewswire/ -- The Pittsburgh Pirates are partnering with Mylan Specialty L.P., the fully-integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), to host the first-ever Pirates Allergy Awareness night at PNC Park on Friday, August 10. The Pirates will reserve a special area of the ballpark for those who have a life-threatening allergy to peanuts, the most common food allergen among children. The Pirates also will provide tips throughout the game to help their fans be more aware of life-threatening allergic reactions, or anaphylaxis.
"Life-threatening allergies are a growing public health problem, particularly among children and teens. In fact, a recent study shows as many as one in 13 children in the U.S. suffer from a food allergy," said Heather Bresch, CEO of Mylan Inc. "We are proud to partner with our hometown team to help the people of Pittsburgh and their family members with life-threatening peanut allergies experience the fun and excitement of a night out at the ball park."
Mylan Specialty L.P. is the official sponsor of the Pittsburgh Pirates' first Allergy Awareness night at PNC Park to take place at the August 10 game against the San Diego Padres. That night, like every Friday home game is a Free Shirt Friday, during which all fans get a complimentary Pirates T-Shirt, with paid admission. To purchase tickets in the peanut-controlled area for this game, please visit www.pirates.com/allergyawareness or call 1-800-BUY-BUCS.
"We are excited to work with Mylan to ensure increased awareness of this important issue, and to help provide a fun experience at PNC Park for our dedicated fans with life-threatening allergies," said Pirates President Frank Coonelly. "Pirates baseball is one of the hottest tickets in town and we want to take steps to ensure all fans are able to enjoy the best ballpark in America."
Throughout the evening, fans will be educated about life-threatening allergies. Because anaphylaxis can happen anywhere and at any time, it is important for everyone to be able to identify and avoid their allergic triggers, recognize anaphylaxis signs and symptoms, and understand how to act quickly and appropriately by seeking emergency care when a life-threatening allergic reaction occurs. In addition, Pirates coach Mark Strittmatter will present a 30-second video about the risks of life-threatening allergies, and encourage fans to visit www.MyAllergySurvey.com.
Pittsburgh Pirates Allergy Awareness Night At-a-Glance:
WHAT: The Pittsburgh Pirates partner with Mylan Specialty L.P. to host the first-ever Allergy Awareness night at PNC Park.
WHEN: Friday, August 10, 2012 – 7:05 p.m. ET
WHERE: PNC Park, 115 Federal St, Pittsburgh, PA. Click here for directions and parking information.
WHO: Pittsburgh Pirates vs. San Diego Padres.
TICKETS: Order tickets for the peanut-controlled section through 1-800-BUY-BUCS or www.pirates.com/allergyawareness.
Anaphylaxis is a life-threatening allergic reaction that has many possible triggers, occurs quickly, without warning, and should be treated immediately with epinephrine. Symptoms may include hives or redness of the skin, tightness in the throat, nausea, dizziness, breathing problems and/or a decrease in blood pressure. Anaphylaxis can be caused by triggers such as food, stinging and biting insects, medicines, latex or even exercise. The most common food allergens that can cause anaphylaxis include cow's milk, eggs, peanuts, tree nuts (walnuts, cashews, pistachios, pecans, etc.), fish, shellfish, soybeans and wheat. Epinephrine is the only first-line treatment for anaphylaxis. Epinephrine is a naturally-occurring hormone, also known as adrenaline, and it should be available at all times to patients at risk. Failure to administer epinephrine early in the course of treatment has been repeatedly implicated with anaphylaxis fatalities.
About Mylan Specialty
Mylan Specialty, a subsidiary of Mylan Inc. (Nasdaq: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, life-threatening allergic reactions and psychiatric disorders. The company puts patients first and facilitates efficient, cost-effective partnerships with customers. For more information, please visit www.mylanspecialty.com.
Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com
SOURCE Mylan Inc.